- Trials with a EudraCT protocol (52)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
52 result(s) found for: Impulsivity.
Displaying page 1 of 3.
| EudraCT Number: 2012-004298-20 | Sponsor Protocol Number: MAMCAC02102014 | Start Date*: 2015-02-03 |
| Sponsor Name:Stockholm Centre for Dependency Disorders | ||
| Full Title: The effect of methylphenidate on executive functioning in amphetamine dependent individuals with ADHD | ||
| Medical condition: Amphetamine dependence | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-001990-25 | Sponsor Protocol Number: BO1 | Start Date*: 2004-09-06 |
| Sponsor Name:Bo Söderpalm | ||
| Full Title: Hur påverkar Remeron alkoholkonsumtionen? How will Remeron influence alcohol consumption in high consumers? | ||
| Medical condition: The subjects in the study will be recruited via an advertisment and will not have a diagnos. We will include males with high consumption of alcohol, defines as 400 grams or more of 100% alcohol per... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-003888-59 | Sponsor Protocol Number: C.2524.0493.01 | Start Date*: 2014-03-17 |
| Sponsor Name:University of Amsterdam | ||
| Full Title: ADHD: Medication or Meditation? | ||
| Medical condition: Attention Deficit Hyperactivity Disorder (ADHD) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003133-34 | Sponsor Protocol Number: OSU1 | Start Date*: 2012-02-29 |
| Sponsor Name:A. Carlsson Research AB | ||
| Full Title: The Effects of the Dopamine Stabilizer (-)-OSU6162 on Craving and Impulsivity in Alcohol Dependent Patients | ||
| Medical condition: Alcohol dependence | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-003435-40 | Sponsor Protocol Number: CTU 0095 | Start Date*: 2006-08-29 | |||||||||||
| Sponsor Name:Department of Health | |||||||||||||
| Full Title: A Randomised Controlled Trial to Investigate the effectiveness of the Healthy Sexual Functioning (HSF) Module and Selective Serotonin Reuptake Inhibitor (SSRI) Medication to treat Deviant Sexual Ar... | |||||||||||||
| Medical condition: Deviant Sexual Arousal (sex offender) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-004455-36 | Sponsor Protocol Number: ATO-TS | Start Date*: 2020-03-10 | |||||||||||
| Sponsor Name:CHU DE POITIERS | |||||||||||||
| Full Title: Evaluation of the effect of Atomoxetine on impulsive state of High impulsive Tourette’s patients. | |||||||||||||
| Medical condition: High impulsive Tourette’s syndrome patients | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-005045-53 | Sponsor Protocol Number: 2014-11-13 | Start Date*: 2015-03-18 |
| Sponsor Name:Landstinget Västmanland | ||
| Full Title: Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivit... | ||
| Medical condition: Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivit... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004004-20 | Sponsor Protocol Number: UI04/6748 | Start Date*: 2005-09-26 |
| Sponsor Name:University of Leeds | ||
| Full Title: A Randomised, Double-blind, Placebo Controlled trial to test the efficacy of St John's Wort (Hypericum Perforatum) for Premenstrual Syndrome. | ||
| Medical condition: The 'premenstrual syndrome' is a cyclical condition occurring 7-10 days before the onset of menstruation, and is relieved at, or shortly after commencement of menstrual flow. The most commonly repo... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-001488-11 | Sponsor Protocol Number: 2014-10-16 | Start Date*: 2015-03-18 |
| Sponsor Name:Landstinget Västmanland | ||
| Full Title: Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivit... | ||
| Medical condition: Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivit... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-012340-16 | Sponsor Protocol Number: EPU P49 | Start Date*: 2009-07-20 |
| Sponsor Name:Maastricht University | ||
| Full Title: Effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy subjects | ||
| Medical condition: To assess the morning versus evening dose effect of hydroxyzine 50 mg on cognition in healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-005103-16 | Sponsor Protocol Number: ETF 5450 | Start Date*: 2005-02-09 |
| Sponsor Name:Estonian Science Foundation | ||
| Full Title: Central serotonergic activity measured by citalopram challenge test and platelet monoamine oxidase activity, associations with gene polymorphism (5-HTTLPR) and impulsivity | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: EE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001284-12 | Sponsor Protocol Number: PA-01 | Start Date*: 2014-11-19 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: The Role of the Dopamine D2 Receptor System in Pornographic Addiction – A [11C]-Raclopride PET Study | ||
| Medical condition: pornographic addiction | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-021024-10 | Sponsor Protocol Number: 019-2010 | Start Date*: 2011-04-19 |
| Sponsor Name:Organisation name was not entered | ||
| Full Title: Anit-Inflammatory treatment to decrease suicidality in patients with a recent suicide attempt and a depressive disorder | ||
| Medical condition: Patients with a recent suicide attempt and a depressive disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003271-35 | Sponsor Protocol Number: KU-AIM-01-2018 | Start Date*: 2019-01-07 | |||||||||||
| Sponsor Name:University of Copenhagen | |||||||||||||
| Full Title: STUDY OF ATTENTION AND IMPULSIVITY IN HEALTHY HUMAN VOLUNTEERS | |||||||||||||
| Medical condition: Attentional deficits and impulsive behaviour. These symptoms are common in attention deficit hyperactivity disorder, but also other conditions affecting the central nervous system such as Alzheimer... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-002161-56 | Sponsor Protocol Number: NeM-CSM-FT-01 | Start Date*: 2017-04-13 |
| Sponsor Name:Mateusz Gola | ||
| Full Title: Towards the understanding of neuronal mechanisms of compulsive sexual behaviors - pharmacotherapy | ||
| Medical condition: compulsive sexual behavior (hypersexual disorder) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: PL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-004115-27 | Sponsor Protocol Number: IIBSP-OXI-2020-102 | Start Date*: 2021-05-10 |
| Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau | ||
| Full Title: Identification and clinical relevance of oxytocin deficient status: randomized, crossover, placebo-controlled pathophysiological pilot study: GLP1 study | ||
| Medical condition: Hypopituitarism | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001909-25 | Sponsor Protocol Number: | Start Date*: Information not available in EudraCT |
| Sponsor Name: | ||
| Full Title: Effekter av behandling med atomoxetine ved komorbid ADHD hos pasienter med Pervasive Developmental Disorders (Effects of treatment with atomoxetine in children with Pervasive Developmental Disorder... | ||
| Medical condition: Open treatment with atomoxetine for 10 weeks: •Week 1: 0,5 mg/kg/day in 1 or 2 doses. •Week 2 – 6: 1,2 mg/kg/day i 1 or 2 doses. •Week 6 – 8: Significant improvements: Continue on 1,2 mg/kg/day in ... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NO (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000992-18 | Sponsor Protocol Number: 12-016 | Start Date*: 2014-09-26 |
| Sponsor Name:UMC Utrecht | ||
| Full Title: Proactive versus reactive inhibition in ADHD: Genetics, neurobiology and pharmacology | ||
| Medical condition: Attention-Deficit Hyperactivity Disorder (ADHD) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-005538-59 | Sponsor Protocol Number: 22-09-2008 | Start Date*: 2009-02-18 |
| Sponsor Name:ZonMw | ||
| Full Title: Impulsivity, a risk factor in relapse to substance use disorder: investigating neural substrates before and after pharmacological challenges | ||
| Medical condition: Alcohol dependence Cocaine dependence | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005330-12 | Sponsor Protocol Number: RAA06-003 | Start Date*: 2006-05-11 |
| Sponsor Name:King's College London (IOP) | ||
| Full Title: Omega-3 Fatty Acids Supplementation for Adolescent Boys with Attention Deficit Hyperactivity Disorder : a double-blind, randomized controlled trial | ||
| Medical condition: Attention deficit / hyperactivity disorder (ADHD) is defined by DSM-IV criteria, which shows inattention, hyperactivity and impulsivity. ADHD is one of the most common child psychiatric disorders,... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Male | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
